Sean Wieland
Stock Analyst at Piper Sandler
(1.87)
# 3,292
Out of 5,090 analysts
31
Total ratings
45.45%
Success rate
1.91%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $40.50 | +35.82% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $23.84 | +51.01% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $4.01 | +2,892.52% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $39.20 | -84.69% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $45.93 | -4.20% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $225.85 | +2.28% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.59 | +3,733.99% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $40.50
Upside: +35.82%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $23.84
Upside: +51.01%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $4.01
Upside: +2,892.52%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $39.20
Upside: -84.69%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $45.93
Upside: -4.20%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $225.85
Upside: +2.28%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.59
Upside: +3,733.99%